| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $20.3M | +31.0% |
| SG&A Expense | $7.4M | -1.1% |
| Operating Income | -$27.7M | -20.6% |
| Pre-tax Income | -$25.9M | -14.0% |
| Income Tax | -$4.7M | -22.6% |
| Net Income | -$21.2M | -12.2% |
| EPS (Basic) | -$2.09 | +2.3% |
| EPS (Diluted) | -$2.09 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.3M | -49.8% |
| Short-term Investments | $4.5M | +1.6% |
| Current Assets | $24.4M | -40.4% |
| Total Assets | $28.1M | -34.1% |
| Current Liabilities | $7.5M | +41.9% |
| Total Liabilities | $7.6M | +43.1% |
| Stockholders' Equity | $15.9M | -57.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.8M | -12.3% |
| Capital Expenditures | $7K | -74.1% |
| Investing Cash Flow | -$7K | +74.1% |
| Financing Cash Flow | $3.0M | -86.2% |
| Free Cash Flow | -$20.8M | -12.2% |
| +2.3% |